- Home
- USAU vs UNCY Comparison
USAU vs UNCY Comparison
Compare USAU & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAU
- UNCY
- Stock Information
- Founded
- USAU N/A
- UNCY 2016
- Country
- USAU United States
- UNCY United States
- Employees
- USAU N/A
- UNCY N/A
- Industry
- USAU Precious Metals
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- USAU Basic Materials
- UNCY Health Care
- Exchange
- USAU Nasdaq
- UNCY Nasdaq
- Market Cap
- USAU 68.1M
- UNCY 70.3M
- IPO Year
- USAU N/A
- UNCY 2021
- Fundamental
- Price
- USAU $6.72
- UNCY $0.62
- Analyst Decision
- USAU Strong Buy
- UNCY Strong Buy
- Analyst Count
- USAU 2
- UNCY 4
- Target Price
- USAU $11.50
- UNCY $5.50
- AVG Volume (30 Days)
- USAU 129.2K
- UNCY 1.3M
- Earning Date
- USAU 12-16-2024
- UNCY 11-13-2024
- Dividend Yield
- USAU N/A
- UNCY N/A
- EPS Growth
- USAU N/A
- UNCY N/A
- EPS
- USAU N/A
- UNCY N/A
- Revenue
- USAU N/A
- UNCY N/A
- Revenue This Year
- USAU N/A
- UNCY N/A
- Revenue Next Year
- USAU N/A
- UNCY N/A
- P/E Ratio
- USAU N/A
- UNCY N/A
- Revenue Growth
- USAU N/A
- UNCY N/A
- 52 Week Low
- USAU $3.20
- UNCY $0.20
- 52 Week High
- USAU $8.62
- UNCY $1.82
- Technical
- Relative Strength Index (RSI)
- USAU 51.58
- UNCY 40.04
- Support Level
- USAU $5.86
- UNCY $0.61
- Resistance Level
- USAU $7.30
- UNCY $0.73
- Average True Range (ATR)
- USAU 0.32
- UNCY 0.07
- MACD
- USAU 0.10
- UNCY -0.02
- Stochastic Oscillator
- USAU 59.72
- UNCY 15.66
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.